Chemoprevention with the metabolism modifying drugs dichloroacetate and metformin in Trp53+/- mice
Main Authors: | Blackburn, AC, Rooke, M, Li, Y, Dahlstrom, JE, Board, PG |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326716/ |
Similar Items
-
Chemoprevention with the metabolism modifying drugs dichloroacetate and metformin in the Li-Fraumeni Syndrome model, Trp53+/- mice
by: Blackburn, Anneke C, et al.
Published: (2014) -
Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells
by: Sun, Ramon C, et al.
Published: (2011) -
Dichloroacetate is an effective treatment for sarcoma models in vitro and in vivo
by: Rooke, Melissa, et al.
Published: (2014) -
The impact of p53 on DNA damage and metabolic activation of the environmental carcinogen benzo[a]pyrene: effects in Trp53(+/+), Trp53(+/–) and Trp53(−/−) mice
by: Krais, Annette M., et al.
Published: (2015) -
Hormonal control of p53 and chemoprevention
by: Jerry, D Joseph, et al.
Published: (2002)